Overview
Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes
Status:
Completed
Completed
Trial end date:
2021-01-10
2021-01-10
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is a plant-based medication used to increase the amount, protect, and reduce HIV's impact on T and B lymphocytes.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Trieu, Nguyen Thi, M.D.
Criteria
Inclusion Criteria:- Participants have a decline in CD4 + T-lymphocytes is the hallmark of HIV-1 infection.
Characterized by rapid loss of resistance: AIDS
- Dermatitis, mouth ulcers, skin rash, itching, weight loss
- HCV (+), HBV (+), Tuberculosis (+)
Exclusion Criteria:
- Cancer under all form